As China bribery scandal widens, Lilly & other US drug makers tout oversight
This article was originally published in Scrip
Like other big US drug makers, Eli Lilly says it has strict rules in place to police its global sales force and prevent representatives from committing the type of crimes alleged last week by a Chinese newspaper.
You may also be interested in...
Using Baxter’s Advate drug as a preventative therapy helped significantly reduce bleeding incidents in a yearlong study.
Mylan CEO Heather Bresch said she is looking to do a sizable deal that helps the US generic and specialty drug maker better compete in a consolidating field of rivals.
Biogen Idec CEO George Scangos is frank about his ambitions to dominate the market for hemophilia therapies, an opportunity he compares to the big biotech’s lead treating multiple sclerosis.